{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:05Z","timestamp":1792730285124,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.expneurol.2026.116015","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:20:03Z","timestamp":1789744803000},"page":"116015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The glycolytic metabolite methylglyoxal drives axon degeneration in vitro and in vivo"],"prefix":"10.1016","volume":"407","author":[{"given":"Gentry","family":"Totta-Griese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent K.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Ryals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley E.","family":"Hurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Crowards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana L.","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexe","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.116015_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnins.2015.00023","article-title":"Methylglyoxal, the dark side of glycolysis","volume":"9","author":"Allaman","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116015_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110635","article-title":"The expanding impact of methylglyoxal on behavior-related disorders","volume":"120","author":"de Almeida","year":"2023","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.expneurol.2026.116015_bb0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuint.2013.08.013","article-title":"Axon degeneration is key component of neuronal death in amyloid-beta toxicity","volume":"63","author":"Alobuia","year":"2013","journal-title":"Neurochem. Int."},{"issue":"10","key":"10.1016\/j.expneurol.2026.116015_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077986","article-title":"Methylglyoxal evokes pain by stimulating TRPA1","volume":"8","author":"Andersson","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/j.pain.0000000000001387","article-title":"Activation of the integrated stress response in nociceptors drives methylglyoxal-induced pain","volume":"160","author":"Barragan-Iglesias","year":"2019","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12987-023-00477-6","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, as a threat for blood brain barrier integrity","volume":"20","author":"Berends","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"12","key":"10.1016\/j.expneurol.2026.116015_bb0035","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"Ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.expneurol.2026.116015_bb0040","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2026.116015_bb0265","series-title":"Diabetic Peripheral Neuropathy. [Update 2024 Feb 25]. In: StatPearls [Internet]","author":"Bodman","year":"2024"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116015_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23986","article-title":"The metabolic syndrome and neuropathy: therapeutic challenges and opportunities","volume":"74","author":"Callaghan","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2026.116015_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2015.01.048","article-title":"Mechanisms of distal axonal degeneration in peripheral neuropathies","volume":"596","author":"Cashman","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"15","key":"10.1016\/j.expneurol.2026.116015_bb0055","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.7150\/thno.36077","article-title":"The role of Na(v)1.7 and methylglyoxal-mediated activation of TRPA1 in itch and hypoalgesia in a murine model of type 1 diabetes","volume":"9","author":"Cheng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.expneurol.2026.116015_bb0060","author":"Clinic"},{"issue":"12","key":"10.1016\/j.expneurol.2026.116015_bb0065","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jat.4515","article-title":"Methylglyoxal-induced neurotoxic effects in primary neuronal-like cells transdifferentiated from human mesenchymal stem cells: impact of low concentrations","volume":"43","author":"Coccini","year":"2023","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116015_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116015_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2025.10.052","article-title":"TLR4 deletion reduces small fiber sensory abnormalities and nerve degeneration in diabetic male mice","volume":"589","author":"Crowards","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.116015_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2025.108558","article-title":"Role of methylglyoxal protein modifications in DNA damage and chromosomal instability: emerging molecular mechanisms","volume":"796","author":"Donnellan","year":"2025","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"34","key":"10.1016\/j.expneurol.2026.116015_bb0085","doi-asserted-by":"crossref","first-page":"28291","DOI":"10.1074\/jbc.M111.328674","article-title":"Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies","volume":"287","author":"Eberhardt","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.expneurol.2026.116015_bb0090","doi-asserted-by":"crossref","first-page":"e1207","DOI":"10.1097\/j.pain.0000000000002667","article-title":"Ketogenic diet prevents methylglyoxal-evoked nociception by scavenging methylglyoxal","volume":"163","author":"Enders","year":"2022","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.expneurol.2026.116015_bb0095","doi-asserted-by":"crossref","first-page":"e1207","DOI":"10.1097\/j.pain.0000000000002667","article-title":"A ketogenic diet prevents methylglyoxal-evoked nociception by scavenging methylglyoxal","volume":"163","author":"Enders","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2026.116015_bb0100","author":"Federation, I.D"},{"issue":"2","key":"10.1016\/j.expneurol.2026.116015_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BST20130265","article-title":"Reactive metabolites as a cause of late diabetic complications","volume":"42","author":"Fleming","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2026.116015_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00679","article-title":"Methylglyoxal requires AC1 and TRPA1 to produce pain and spinal neuron activation","volume":"11","author":"Griggs","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116015_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2019.02.019","article-title":"Methylglyoxal and a spinal TRPA1-AC1-Epac cascade facilitate pain in the db\/db mouse model of type 2 diabetes","volume":"127","author":"Griggs","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116015_bb0120","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0201-21.2021","article-title":"The type 2 diabetes factor methylglyoxal mediates axon initial segment shortening and alters neuronal function at the cellular and network levels","volume":"8","author":"Griggs","year":"2021","journal-title":"eNeuro"},{"issue":"10","key":"10.1016\/j.expneurol.2026.116015_bb0125","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc20-0586","article-title":"National and state-level trends in nontraumatic lower-extremity amputation among U.S. Medicare beneficiaries with diabetes, 2000-2017","volume":"43","author":"Harding","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.expneurol.2026.116015_bb0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.metabol.2015.12.002","article-title":"Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels","volume":"65","author":"Huang","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.expneurol.2026.116015_bb0135","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s00125-011-2196-3","article-title":"Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy","volume":"54","author":"Jack","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2011.12.015","article-title":"Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?","volume":"234","author":"Jack","year":"2012","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.expneurol.2026.116015_bb0145","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.chembiol.2020.07.016","article-title":"Small substrate or large? Debate over the mechanism of glycation adduct repair by DJ-1","volume":"27","author":"Jun","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116015_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"issue":"Pt 3","key":"10.1016\/j.expneurol.2026.116015_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.expneurol.2016.06.016","article-title":"Epidermal innervation as a tool to study human axonal regeneration and disease progression","volume":"287","author":"Khoshnoodi","year":"2017","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3346\/jkms.2004.19.1.95","article-title":"Methylglyoxal induces apoptosis mediated by reactive oxygen species in bovine retinal pericytes","volume":"19","author":"Kim","year":"2004","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phrs.2011.10.006","article-title":"Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy","volume":"65","author":"Koivisto","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116015_bb0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-510X(99)00063-5","article-title":"Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy","volume":"164","author":"Lauria","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116015_bb0175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","article-title":"Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study","volume":"15","author":"Lauria","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116015_bb0180","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jnc.13436","article-title":"The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen-glucose deprivation","volume":"136","author":"Li","year":"2016","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.expneurol.2026.116015_bb0185","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/CS20140683","article-title":"The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases","volume":"128","author":"Maessen","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nprot.2006.461","article-title":"Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity","volume":"2","author":"Malin","year":"2007","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116015_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/10738584231162508","article-title":"SARM1-dependent axon degeneration: nucleotide signaling, neurodegenerative disorders, toxicity, and therapeutic opportunities","volume":"30","author":"McGuinness","year":"2023","journal-title":"Neuroscientist"},{"issue":"10","key":"10.1016\/j.expneurol.2026.116015_bb0200","article-title":"The glyoxalase system-new insights into an ancient metabolism","volume":"9","author":"Morgenstern","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0205","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1038\/s41598-018-27108-7","article-title":"Investigating the glycating effects of glucose, glyoxal and methylglyoxal on human sperm","volume":"8","author":"Nevin","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116015_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12050939","article-title":"Methylglyoxal and advanced glycation end products (AGEs): targets for the prevention and treatment of diabetes-associated bladder dysfunction?","volume":"12","author":"Oliveira","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.expneurol.2026.116015_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2017.05.006","article-title":"Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy","volume":"49","author":"Rabbani","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116015_bb0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s12276-021-00561-7","article-title":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","volume":"53","author":"Rungratanawanich","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1152\/physrev.00001.2019","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases","volume":"100","author":"Schalkwijk","year":"2020","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116015_bb0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1389200217666151222155216","article-title":"Methylglyoxal, a metabolite increased in diabetes is associated with insulin resistance, vascular dysfunction and neuropathies","volume":"17","author":"Shamsaldeen","year":"2016","journal-title":"Curr. Drug Metab."},{"issue":"11","key":"10.1016\/j.expneurol.2026.116015_bb0235","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0006-2952(01)00603-7","article-title":"Cytotoxic action of methylglyoxal on insulin-secreting cells","volume":"61","author":"Sheader","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.116015_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1161077","article-title":"Abnormal intraepidermal nerve fiber density in disease: a scoping review","volume":"14","author":"Thomas","year":"2023","journal-title":"Front. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.116015_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/DMDI.2008.23.1-2.125","article-title":"Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease","volume":"23","author":"Thornalley","year":"2008","journal-title":"Drug Metabol. Drug Interact."},{"key":"10.1016\/j.expneurol.2026.116015_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13098-016-0146-4","article-title":"The usefulness of quantifying intraepidermal nerve fibers density in the diagnostic of diabetic peripheral neuropathy: a cross-sectional study","volume":"8","author":"Timar","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116015_bb0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jns.12219","article-title":"Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy","volume":"22","author":"Turkiew","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2026.116015_bb0260","doi-asserted-by":"crossref","DOI":"10.1177\/17448069241233744","article-title":"Methylglyoxal activates transient receptor potential A1\/V1 via reactive oxygen species in the spinal dorsal horn","volume":"20","author":"Ueno","year":"2024","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11892-013-0453-1","article-title":"Advanced glycation end products (AGE) and diabetes: cause, effect, or both?","volume":"14","author":"Vlassara","year":"2014","journal-title":"Curr. Diab. Rep."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116015_bb0275","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BST20130254","article-title":"Reducing methylglyoxal as a therapeutic target for diabetic heart disease","volume":"42","author":"Vulesevic","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2026.116015_bb0280","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1196\/annals.1338.067","article-title":"Role of advanced glycation end products and their receptors in development of diabetic neuropathy","volume":"1043","author":"Wada","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2026.116015_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116526","article-title":"Methylglyoxal - an advanced glycation end products (AGEs) precursor - inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE)","volume":"164","author":"Waqas","year":"2022","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.expneurol.2026.116015_bb0290","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116015_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004649","article-title":"A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116015_bb0300","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/0008-5472.CAN-17-1467","article-title":"Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery","volume":"78","author":"Wozniak","year":"2018","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.expneurol.2026.116015_bb0305","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1021\/bi500046t","article-title":"The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs","volume":"53","author":"Xue","year":"2014","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.2040-1124.2010.00070.x","article-title":"Mechanism of diabetic neuropathy: where are we now and where to go?","volume":"2","author":"Yagihashi","year":"2011","journal-title":"J. Diabetes Investig."},{"issue":"10","key":"10.1016\/j.expneurol.2026.116015_bb0315","first-page":"C1045","article-title":"Prolonged exposure to methylglyoxal causes disruption of vascular KATP channel by mRNA instability","volume":"303","author":"Yang","year":"2012","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116015_bb0320","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116015_bb0325","first-page":"827","article-title":"Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons","volume":"74","author":"Yousuf","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2026.116015_bb0330","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448862600381X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448862600381X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:59:40Z","timestamp":1792727980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448862600381X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":66,"alternative-id":["S001448862600381X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The glycolytic metabolite methylglyoxal drives axon degeneration in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116015"}}